Create Medic Co., Ltd. (5187) AI Stock Analysis

• Market Cap: ¥8.96B
• Dividend Yield: 3.76%
• Average Volume (3M): 12.00K
• Price to Earnings (P/E): 12.0
• Beta (1Y): 0.19
• Revenue Growth: 3.38%
• EPS Growth: 88.65%
• Country: JP
• Employees: 1,002
• Sector: Healthcare
• Sector Strength: 54
• Industry: Medical - Devices
• EPS (TTM): 23.97
• Shares Outstanding: 9,664,327
• 10 Day Avg. Volume: 8,660
• 30 Day Avg. Volume: 12,003
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 78 Outperform
• Price Target: ―

Create Medic Co., Ltd. receives a strong score based on its robust financial performance, underpinned by significant revenue growth and improved profitability. The valuation is attractive with a low P/E ratio and high dividend yield, appealing to value and income investors. However, the lack of positive momentum in technical analysis slightly tempers the overall score.

Create Medic Co., Ltd. Business Overview & Revenue Model

Company Description

Create Medic Co., Ltd. researches, develops, manufactures, and sells medical appliances in Japan and internationally. The company offers disposable medical devices made of silicone resin. It provides various urology, gastroenterology, percutaneous endoscopic gastrostomy, and surgery products. The company also provides other products, such as CLINY tracheostomy tubes, endotracheal tubes, tracheostomy tubes, and microcatheters. In addition, it offers OEM products comprising multi-lumen tubes, ultrathin walls, profile extrusions, and special structures; special shape and high-volume low-pressure cuff moldings; and hydrophilic coating and needles, as well as the technology on an OEM basis. The company was formerly known as NASK Co., Ltd. and changed its name to Create Medic Co., Ltd. in July 1977. Create Medic Co., Ltd. was incorporated in 1974 and is headquartered in Yokohama, Japan.

How the Company Makes Money

Create Medic Co., Ltd. generates revenue through the sale of its medical devices and equipment to healthcare facilities such as hospitals and clinics. The company's primary revenue stream comes from its extensive catalog of products, including catheters and drainage tubes, which are critical for numerous medical applications. By maintaining strong relationships with healthcare providers and ensuring high-quality manufacturing standards, Create Medic sustains its market presence and competitiveness. Additionally, the company may benefit from partnerships with medical distributors and direct sales efforts, which help expand its reach in both domestic and international markets. The demand for reliable and innovative medical devices, a growing healthcare industry, and advancements in medical technology contribute significantly to the company's earnings.

Create Medic Co., Ltd. Financial Statement Overview

Summary

Create Medic Co., Ltd. exhibits a robust financial profile with commendable revenue growth, improved profitability, and a strong balance sheet with low leverage. The cash flow statements further reinforce the company's solid financial health, demonstrating efficient cash management and operational strength.

Income Statement

Create Medic Co., Ltd. demonstrates strong revenue growth from ¥12.6 billion in 2023 to ¥13.03 billion in 2024, indicating a healthy expansion trajectory. The gross profit margin remains robust at around 43.8%, complemented by a solid net profit margin improvement to 6.4% from 1.2% the prior year. The company also shows consistent EBIT and EBITDA margins, reflecting operational efficiency.

Balance Sheet

The balance sheet is strong with a low debt-to-equity ratio of 0.05, suggesting low financial leverage. The equity ratio is high at 78.6%, indicating a solid equity base. Return on equity improved to 5.3% from 1.0%, showcasing enhanced shareholder value creation.

Cash Flow

Operating cash flow grew significantly, indicating improved cash-generating capabilities, while free cash flow remains positive at ¥1.86 billion. The operating cash flow to net income ratio of 2.68 highlights strong cash flow relative to profits.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	13.27B	13.03B	12.59B	12.33B	11.70B	10.83B
Gross Profit	5.80B	5.70B	5.48B	5.37B	5.26B	5.08B
EBITDA	1.85B	1.73B	1.50B	1.47B	1.43B	1.40B
Net Income	990.63M	840.90M	154.02M	482.21M	660.41M	659.52M
Balance Sheet
Total Assets	19.10B	20.05B	19.26B	18.87B	18.08B	17.10B
Cash, Cash Equivalents and Short-Term Investments	5.76B	6.32B	4.39B	4.31B	4.36B	3.97B
Total Debt	851.89M	800.00M	800.00M	800.00M	800.00M	892.40M
Total Liabilities	3.75B	4.30B	4.31B	4.14B	3.86B	3.87B
Stockholders Equity	15.35B	15.75B	14.94B	14.72B	14.22B	13.23B
Cash Flow
Free Cash Flow	0.00	1.77B	246.98M	101.75M	629.58M	839.00M
Operating Cash Flow	0.00	2.25B	698.84M	461.34M	1.25B	1.25B
Investing Cash Flow	0.00	270.62M	-363.61M	38.01M	-585.01M	-704.31M
Financing Cash Flow	0.00	-877.65M	-362.19M	-355.59M	-442.52M	-845.03M

Create Medic Co., Ltd. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 985.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:5187, the sentiment is Positive. The current price of 985 is above the 20-day moving average (MA) of 983.95, above the 50-day MA of 963.26, and above the 200-day MA of 920.35, indicating a bullish trend. The MACD of 6.23 indicates Positive momentum. The RSI at 55.07 is Neutral, neither overbought nor oversold. The STOCH value of 54.32 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:5187.

Create Medic Co., Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
5187	78 Outperform	¥8.96B	11.98		3.76%	3.38%	88.65%
Sector *	51 Neutral	$7.83B	-0.18	-40.01%	2.28%	22.68%	-1.83%
DMTRF	―	$166.30M	―	-184.59%	―	―	―
7792	77 Outperform	¥13.10B	10.40		2.08%	12.36%	38.55%
7963	75 Outperform	¥8.95B	11.58		1.92%	9.07%	43.42%
6678	74 Outperform	¥16.94B	16.25		3.42%	-8.07%	-38.21%
7600	56 Neutral	¥13.69B	10.23		2.88%	4.84%	-148.94%

Create Medic Co., Ltd. Corporate Events

Create Medic Reports Mixed Financial Results for First Half of 2025

Create Medic Co., Ltd. reported its consolidated financial results for the first half of 2025, showing a 4.2% increase in net sales compared to the previous year. Despite a significant rise in operating and ordinary profits, the profit attributable to owners of the parent decreased by 25%. The company maintained a strong capital adequacy ratio of 84.0% and announced a forecasted annual dividend of 37 yen per share. These results indicate a mixed performance, with growth in sales and profits but a decline in net income, which may affect stakeholder confidence.